Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Endometriosis
Age: Adult
Condition: Mild hepatic impairment (Child-Pugh A)
Dose: 150 mg
Frequency: once daily
Duration: up to 24 months
Note: No dosage adjustment required
Indication: Endometriosis
Age: Adult
Condition: Moderate hepatic impairment (Child-Pugh B)
Dose: 150 mg
Frequency: once daily
Duration: limited to 6 months
Note: Only the 150-mg once daily regimen is recommended

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: Tablet – No approved pediatric dosage available
Note: No approved pediatric dosage available

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment
Dose: Not mentioned
Note: No dosage adjustment required with any degree of renal impairment or end-stage renal disease (including dialysis)
Administration
  • Take once daily
  • With or without food
Side Effect

Drug Interaction

Drug NameRisk Factors
Cyclosporine, gemfibrozil
Contraindicated
Digoxin, ethinylestradiol
Increases exposure

Disease Interaction

Disease NameRisk Factors
Known Osteoporosis
Risk of bone loss
Severe Hepatic Impairment
Risk of drug toxicity

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.